(6R,7R)-8-Oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-3-[(1,3,4-thiadiazol-2-ylsulfanyl)methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid(CAS: 26973-24-0)

This compound is subject to the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), which includes specific hazard classification and labeling requirements. For European markets, REACH regulations also apply, mandating registration, evaluation, and authorization. In the USA, FDA and EPA regulations may be applicable for certain uses, particularly in pharmaceutical and environmental contexts.

There are various alternatives that can be used in synthesis depending on the desired properties. Analogous compounds or isomers with similar functional groups might serve as viable alternatives. Common alternative reagents include other tetrazoles, thiadiazoles, and carboxylic acids with similar functionalities, which can offer similar or improved characteristics in different applications.

The market and research trends for this compound indicate increasing interest in its use in pharmaceuticals and biotechnological applications due to its unique chemical structure and potential biological activities. Recent research focuses on its use as an inhibitor and its role in various physiological processes. Market trends suggest growing demand for this compound in academic and industrial research settings.

Waste containing this compound should be collected in appropriate containers and disposed of in accordance with local regulations. Incineration is a common method for disposal, but professional waste disposal services are recommended for safety and compliance. Environmental precautions include ensuring no release into water bodies and proper handling to prevent contamination. Always consult local and national regulations for specific disposal procedures.